Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
17.92
-0.58 (-3.14%)
At close: Feb 13, 2026, 4:00 PM EST
17.85
-0.07 (-0.39%)
After-hours: Feb 13, 2026, 7:34 PM EST
Monte Rosa Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$29.50
Upside
+64.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $28 → $37 | Buy | Reiterates | $28 → $37 | +106.47% | Jan 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $22 → $30 | Buy | Maintains | $22 → $30 | +67.41% | Jan 8, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $16 → $34 | Strong Buy | Maintains | $16 → $34 | +89.73% | Jan 8, 2026 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $13 → $22 | Hold → Buy | Upgrades | $13 → $22 | +22.77% | Dec 16, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $10 → $13 | Hold | Maintains | $10 → $13 | -27.46% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | -44.20% | Mar 21, 2025 |
| Wedbush | Wedbush | Buy Maintains $15 → $17 | Buy | Maintains | $15 → $17 | -5.13% | Mar 21, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $14 → $11 | Buy → Hold | Downgrades | $14 → $11 | -38.62% | Dec 19, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $14 | Buy | Maintains | $17 → $14 | -21.88% | Nov 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | -38.62% | Sep 12, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | -5.13% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $16 | Buy | Reiterates | $16 | -10.71% | Jun 28, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | -38.62% | May 22, 2024 |
| Wedbush | Wedbush | Buy Initiates $11 | Buy | Initiates | $11 | -38.62% | Feb 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $31 → $11 | Buy | Maintains | $31 → $11 | -38.62% | Oct 19, 2023 |
| Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | -38.62% | Aug 11, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.